OBJECTIVE: To investigate the long-term effects of the Canadian folic acid fortification program in older adults' whole blood cell folate (folate) and cobalamin (Cbl) status, including homocysteine (tHcy) and methylmalonic acid (MMA), with and without voluntary B-vitamin intake, from 1997 to 2004. METHODS: Cohort of community-dwelling volunteer older adults. Clinical and biochemical data, including intake of B-vitamin supplements, were obtained at 2- to 2.5-year intervals and divided in 4 periods. Random coefficients (mixed effects) models were used to estimate the linear trend in folate and to compare levels of biochemical parameters between periods. All models were estimated by restricted maximum likelihood as implemented in PROC MIXED of SAS V8.2. RESULTS: Folate levels increased continuously at a yearly rate of 234 ng/mL (95% CI 213-254; p < 0.001) and had not plateaued by the last period when 84% of subjects without B-vitamins had elevated folate. Homocysteine did not remain suppressed. Elevated tHcy was as prevalent in the last study period as in the first. No significant deficits of Cbl or increases of MMA were observed, but MMA levels tended to increase with time in subjects without B-vitamins. B-vitamin supplements significantly affected all results, reducing tHcy and MMA levels. CONCLUSION: In this population, fortification with folic acid has resulted in cumulative increases of folate with no long-term reduction in tHcy or changes in Cbl or MMA. Possible deleterious effects of cumulative increases of folate, and beneficial effects of B-vitamin supplements in reducing tHcy and MMA, should be investigated.
OBJECTIVE: To investigate the long-term effects of the Canadian folic acid fortification program in older adults' whole blood cell folate (folate) and cobalamin (Cbl) status, including homocysteine (tHcy) and methylmalonic acid (MMA), with and without voluntary B-vitamin intake, from 1997 to 2004. METHODS: Cohort of community-dwelling volunteer older adults. Clinical and biochemical data, including intake of B-vitamin supplements, were obtained at 2- to 2.5-year intervals and divided in 4 periods. Random coefficients (mixed effects) models were used to estimate the linear trend in folate and to compare levels of biochemical parameters between periods. All models were estimated by restricted maximum likelihood as implemented in PROC MIXED of SAS V8.2. RESULTS:Folate levels increased continuously at a yearly rate of 234 ng/mL (95% CI 213-254; p < 0.001) and had not plateaued by the last period when 84% of subjects without B-vitamins had elevated folate. Homocysteine did not remain suppressed. Elevated tHcy was as prevalent in the last study period as in the first. No significant deficits of Cbl or increases of MMA were observed, but MMA levels tended to increase with time in subjects without B-vitamins. B-vitamin supplements significantly affected all results, reducing tHcy and MMA levels. CONCLUSION: In this population, fortification with folic acid has resulted in cumulative increases of folate with no long-term reduction in tHcy or changes in Cbl or MMA. Possible deleterious effects of cumulative increases of folate, and beneficial effects of B-vitamin supplements in reducing tHcy and MMA, should be investigated.
Authors: P F Jacques; I H Rosenberg; G Rogers; J Selhub; B A Bowman; E W Gunter; J D Wright; C L Johnson Journal: Am J Clin Nutr Date: 1999-03 Impact factor: 7.045
Authors: I M Graham; L E Daly; H M Refsum; K Robinson; L E Brattström; P M Ueland; R J Palma-Reis; G H Boers; R G Sheahan; B Israelsson; C S Uiterwaal; R Meleady; D McMaster; P Verhoef; J Witteman; P Rubba; H Bellet; J C Wautrecht; H W de Valk; A C Sales Lúis; F M Parrot-Rouland; K S Tan; I Higgins; D Garcon; G Andria Journal: JAMA Date: 1997-06-11 Impact factor: 56.272
Authors: M R Malinow; P B Duell; D L Hess; P H Anderson; W D Kruger; B E Phillipson; R A Gluckman; P C Block; B M Upson Journal: N Engl J Med Date: 1998-04-09 Impact factor: 91.245
Authors: Angeles A Garcia; Yafa Haron; Lisa R Evans; Matthew G Smith; Morris Freedman; Gustavo C Roman Journal: J Am Geriatr Soc Date: 2004-01 Impact factor: 5.562
Authors: Joyce B J van Meurs; Rosalie A M Dhonukshe-Rutten; Saskia M F Pluijm; Marjolein van der Klift; Robert de Jonge; Jan Lindemans; Lisette C P G M de Groot; Albert Hofman; Jacqueline C M Witteman; Johannes P T M van Leeuwen; Monique M B Breteler; Paul Lips; Huibert A P Pols; André G Uitterlinden Journal: N Engl J Med Date: 2004-05-13 Impact factor: 91.245
Authors: Joel B Mason; Aaron Dickstein; Paul F Jacques; Paul Haggarty; Jacob Selhub; Gerard Dallal; Irwin H Rosenberg Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-07 Impact factor: 4.254
Authors: Truong-Minh Pham; John Paul Ekwaru; Silmara S Mastroeni; Marco F Mastroeni; Sarah A Loehr; Paul J Veugelers Journal: PLoS One Date: 2016-08-22 Impact factor: 3.240